465 related articles for article (PubMed ID: 9779349)
1. Current and future therapy of invasive fungal infections.
Andriole VT
Curr Clin Top Infect Dis; 1998; 18():19-36. PubMed ID: 9779349
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
3. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
4. Management of systemic fungal infections: alternatives to itraconazole.
Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
[TBL] [Abstract][Full Text] [Related]
5. [Choice and use of antifungal drugs].
Dupont B
Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
[TBL] [Abstract][Full Text] [Related]
6. Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Chanock SJ; Walsh TJ
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S15-20. PubMed ID: 8971401
[TBL] [Abstract][Full Text] [Related]
7. Current drug therapy of systemic mycoses: a review.
Yonga G
East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014
[TBL] [Abstract][Full Text] [Related]
8. Systemic fungal infections: diagnosis and treatment. I. Therapeutic agents.
Graybill JR
Infect Dis Clin North Am; 1988 Dec; 2(4):805-25. PubMed ID: 3062088
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the treatment of systemic mycotic infections.
Codish SD; Tobias JS; Monaco AP
Surg Gynecol Obstet; 1979 Mar; 148(3):435-47. PubMed ID: 369010
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
Viscoli C; Castagnola E
Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
[TBL] [Abstract][Full Text] [Related]
11. Drugs for treatment of systemic fungal infections.
Med Lett Drugs Ther; 1986 Apr; 28(711):41-4. PubMed ID: 3959988
[No Abstract] [Full Text] [Related]
12. [Antimycotic agents in generalized fungal infections].
van 't Wout JW; van Furth R
Ned Tijdschr Geneeskd; 1988 May; 132(20):900-4. PubMed ID: 3374679
[No Abstract] [Full Text] [Related]
13. Lipid formulations of amphotericin B.
Dix SP; Andriole VT
Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
[TBL] [Abstract][Full Text] [Related]
14. Candida endophthalmitis: focus on current and future antifungal treatment options.
Khan FA; Slain D; Khakoo RA
Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
[TBL] [Abstract][Full Text] [Related]
15. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
16. Antifungal agents used for deep-seated mycotic infections.
Terrell CL; Hermans PE
Mayo Clin Proc; 1987 Dec; 62(12):1116-28. PubMed ID: 3682956
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy of systemic fungal infections, Part II.
Gross M
N C Med J; 1984 Sep; 45(9):551-3. PubMed ID: 6592453
[No Abstract] [Full Text] [Related]
18. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Ho DY; Lee JD; Rosso F; Montoya JG
Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Jullien V
Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
[TBL] [Abstract][Full Text] [Related]
20. Antifungal agents and immunomodulators in systemic mycoses.
Khan ZK; Jain P
Indian J Chest Dis Allied Sci; 2000; 42(4):345-55. PubMed ID: 15597684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]